Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ProShares Ultra Nasdaq Biotechnology BIB

The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the funds investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq... see more

Recent & Breaking News (NDAQ:BIB)

    Biotechs Are Ripping Following IPAB Ruling

    Benzinga.com  June 22, 2016

    ProShares Expands Largest Lineup of Leveraged and Inverse ETFs

    Business Wire June 23, 2015

    ProShares Announces ETF Share Splits

    Business Wire May 1, 2015

    NASDAQ OMX Global Indexes Announces Methodology Changes to the NASDAQ Biotechnology Index

    Globe Newswire June 10, 2013

    ProShares Launches Listed Private Equity ETF

    Business Wire February 28, 2013

    ProShares Lowers Net Expense Ratio for CSM, a Morningstar Rated 5-Star ETF

    Business Wire February 7, 2013